AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Simmagluetide: The Future of Diabetes
Simmagluetide's medication belongs to the class of drugs known as glucagon-like peptide 1 receptor agonists. GLP1 is a naturally occurring hormone that plays a role in glucose regulation and in appetite control. In 2004, they started some clinical trials to look at efficacy and safety which showed this effectively reduced blood sugar levels and promoted weight loss. And there's ongoing research looking at whether or not it has potential benefit in other areas like cardiovascular disease, non-alcoholic fatty liver disease, etc.